Stéphane Decap, Genetics Product Manager, CliniSys | MIPS: Genomic testing is complex. Why do clinicians need GLIMS Genomics Clinical?
It also integrates with hospital electronic patient record systems, using a HL7 interface. GLIMS Genomics Clinical helps clinicians run their clinics, order tests electronically, and manage their patients’ genomic records. Now, we are opening it up to clinicians working with patients and families. So, what is GLIMS Genomics Clinical?Įmma: Until now, GLIMS Genomics has been a laboratory system, used by laboratory staff. In short, genomic laboratories need a modern, dedicated laboratory information management system, and that is what GLIMS Genomics delivers. They require an automated, streamlined approach that can increase sample throughput, standardise workflows, and improve efficiency to deliver results back to clinicians rapidly along with the information required for result interpretation. Genomics laboratories need to move away from receiving orders on paper and managing samples on spreadsheets. It is also attracting a lot of interest in the rest of the UK, as genomic testing is evolving and becoming an established diagnostic tool for an increasing number of patients. Since then, it has gone live at 2 additional laboratories in France, a further 5 across Europe are in the preparatory stages for implementation with the first NHS Trust site in the UK due to go live in 2022. It was launched in the UK in November 2020, following a successful first deployment at Poitiers University Hospital in France. Let’s start with a quick reminder: what is GLIMS Genomics?Įmma Huntridge, Genomics Business Development Director, CliniSys: GLIMS Genomics is a laboratory information management system built to meet the requirements of genomic laboratories. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genomics Clinical to clinicians, laboratories, patients and their families. Now, it has launched a clinical counterpart to the system. Last year, CliniSys brought its genomics LIMS to the UK, following a successful phase of development and deployment on the continent.
0 kommentar(er)
